This company has been acquired
Oak Street Health Future Growth
Future criteria checks 3/6
Oak Street Health is forecasted to grow earnings and revenue by 53.6% and 23.4% per annum respectively. EPS is expected to grow by 55.2%. Return on equity is forecast to be 31.9% in 3 years.
Key information
53.6%
Earnings growth rate
55.2%
EPS growth rate
| Healthcare earnings growth | 12.3% |
| Revenue growth rate | 23.4% |
| Future return on equity | 31.9% |
| Analyst coverage | Good |
| Last updated | 02 May 2023 |
Recent future growth updates
Recent updates
CVS close to acquiring Oak Street Health for $10.5B - WSJ
Feb 07Oak Street Health jumps on report of CVS takeover interest
Jan 09Oak Street Health pares gain on report about takeover chances
Nov 16Oak Street Health Q3 2022 Earnings Preview
Nov 07Oak Street Health downgraded at Goldman Sachs citing cloudy outlook
Sep 12Oak Street Health slips aftermarket on secondary stock offering
Aug 16Oak Street Health Q2 2022 Earnings Preview
Aug 01Oak Street Health, Inc. (NYSE:OSH) Shares Could Be 28% Above Their Intrinsic Value Estimate
Jan 28
Oak Street Health Grows Revenue But Struggles With Higher Medical Costs
Dec 22Oak Street Health: Poised For Growth Following RubiconMD Deal
Dec 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 5,215 | -120 | -88 | 117 | 5 |
| 12/31/2024 | 4,117 | -263 | -191 | -84 | 14 |
| 12/31/2023 | 3,053 | -363 | -289 | -227 | 17 |
| 12/31/2022 | 2,161 | -509 | -399 | -309 | N/A |
| 9/30/2022 | 1,977 | -515 | -393 | -285 | N/A |
| 6/30/2022 | 1,820 | -494 | -398 | -295 | N/A |
| 3/31/2022 | 1,650 | -442 | -353 | -260 | N/A |
| 12/31/2021 | 1,430 | -409 | -278 | -197 | N/A |
| 9/30/2021 | 1,285 | -358 | -230 | -181 | N/A |
| 6/30/2021 | 1,114 | -282 | -147 | -116 | N/A |
| 3/31/2021 | 976 | -159 | -94 | -69 | N/A |
| 12/31/2020 | 883 | -120 | -98 | -77 | N/A |
| 9/30/2020 | 808 | -85 | -77 | -57 | N/A |
| 6/30/2020 | 729 | -93 | -103 | -79 | N/A |
| 3/31/2020 | 641 | -145 | -88 | -63 | N/A |
| 12/31/2019 | 557 | -137 | -83 | -55 | N/A |
| 9/30/2019 | 470 | -119 | -65 | -35 | N/A |
| 12/31/2018 | 318 | -119 | -101 | -75 | N/A |
| 12/31/2017 | 185 | -55 | -48 | -35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OSH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OSH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OSH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OSH's revenue (23.4% per year) is forecast to grow faster than the US market (7.4% per year).
High Growth Revenue: OSH's revenue (23.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OSH's Return on Equity is forecast to be high in 3 years time (31.9%)